Anna Subbotina,
Eystein Skjølsvik,
Marit Dahl Solbu,
Atena Miroslawska,
Terje Kristian Steigen
:
Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension, the ReShape CV-risk study
Tove Aminda Hanssen,
Anna Subbotina,
Atena Miroslawska,
Marit Dahl Solbu,
Terje Steigen
:
Quality of life following renal sympathetic denervation in treatment-resistant hypertensive patients: a two-year follow-up study
Scandinavian Cardiovascular Journal 2022
ARKIV /
DOI
Atena Miroslawska,
Petter Fosse Gjessing,
Marit Dahl Solbu,
Jon Viljar Norvik,
Ole Martin Fuskevåg,
Tove Aminda Hanssen
et al.:
Metabolic effects two years after renal denervation in insulin resistant hypertensive patients. The Re-Shape CV-risk study
Clinical Nutrition 2021
DOI
Marit D. Solbu,
Atena Miroslawska,
Jon V. Norvik,
Bjørn O. Eriksen,
Terje K. Steigen
:
Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV-Risk Study
The Journal of Clinical Hypertension 2021
ARKIV /
DOI
Alexandre Persu,
Daniel Gordin,
Lotte Jacobs,
Lutgarde Thijs,
Michiel L Bots,
Wilko Spiering
et al.:
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-levelmeta-analysis
Journal of Hypertension 2017
DOI
Atena Kazimiera Miroslawska,
Petter Fosse Gjessing,
Marit Dahl Solbu,
Ole-Martin Fuskevåg,
Trond Geir Jenssen,
Terje Steigen
:
Renal denervation for resistant hypertension fails to improve insulin resistance as assessed by hyperinsulinemic-euglycemic step clamp
A Miroslawska,
Marit Dahl Solbu,
Eystein Skjölsvik,
Ingrid Toft,
TK Steigen
:
Renal sympathetic denervation: effect on ambulatory blood
pressure and blood pressure variability in patients with
treatment-resistant hypertension. The ReShape CV-risk study
Journal of Human Hypertension 2016
DOI
Bente Nilsen,
Lena Nordgaard Dehli,
Atena Kazimiera Miroslawska,
Tove Aminda Hanssen
:
Smertelindring ved renal denervering
Sykepleien Forskning 2015
DOI